-
Diagnostics World News | Experiences at the Mayo Clinic integrating metagenomic next-generation sequencing into clinical practice was one of the featured presentations at the recent Next Generation Dx Summit in Washington, D.C. Keynote speaker Robin M. Patel, M.D., focused primarily on the use of the targeted-based approach where the 16S ribosomal RNA (rRNA) gene is being analyzed.
Oct 5, 2022
-
Diagnostics World News | A team of researchers from Stanford University and the Georgia Institute of Technology designed a malleable, battery-operated wearable sensor that continuously monitors subcutaneous tumor progression, regression, and treatment efficacy.
Oct 4, 2022
-
Diagnostics World News | An RNA-based diagnostic workflow for detecting mRNA expression of standard breast cancer biomarkers; an automated TB test for immunocompromised patients; a companion diagnostic for detecting genomic alterations; and more.
Sep 29, 2022
-
Diagnostics World News | Funding for voice-based diagnostics, machine learning algorithms that detect and stratify pulmonary hypertension, immunohistochemistry cancer diagnostics, and more.
Sep 28, 2022
-
Diagnostics World News | Emerging approaches to the early detection of cancer were highlighted during the recent Next Generation Dx Summit held in Washington, D.C. Representatives from diagnostics companies Oxomics, Elypta, Micronoma, and Rivela Diagnostics took turns making their case for a new generation of technologies hunting for elusive molecular signatures of a highly heterogenous group of diseases.
Sep 22, 2022
-
Diagnostics World News | Ongoing collaboration between the fields of immunotherapy and liquid biopsy has opened vast opportunities to improve the care of cancer patients, including the prevention of full-blown disease or relapse. It was also the focus of several talks at the recent Next Generation Dx Summit, including a keynote on the long-hoped-for promise of liquid biopsy approaches for diagnosing and treating solid tumors.
Sep 21, 2022
-
Diagnostics World News | The National Institutes of Health (NIH) seeks to award up to $300 million to diagnostic test manufacturers for developing improved next-generation COVID-19 tests. The two main objectives will be to increase testing performance and accessibility.
Sep 20, 2022
-
Diagnostics World News | The greater New York metropolitan area is the epicenter of an ambitious human genome sequencing research project newly launched by Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai. If the vision is realized, Mount Sinai will enroll a million patients into a study over the next five years that will sequence and analyze the DNA in their blood to tease out the role of genetics and environment on health.
Sep 15, 2022
-
Diagnostics World News | The impact of Europe’s In Vitro Diagnostic Medical Devices Regulation on global trials for precision medicine was shared at the recent Next Generation Dx Summit held in Washington, DC. IVDR is finally coming into force and creating “significant challenges” for pharmaceutical companies sponsoring studies involving biomarker testing on EU patient samples.
Sep 13, 2022
-
Diagnostics World News | Researchers at Tulane University and Ochsner Health have characterized carotid plaque taken from patients within days of a stroke, confirming that ruptures are associated with the thinning of the fibrous cap stabilizing the fatty deposits as well as suggesting that B cells play a bigger role than has previously been appreciated.
Sep 7, 2022
-
Diagnostics World | Recently published findings and emerging studies are taking a closer look at the relationship between cognitive and vascular health, adding to our collective understanding of dementia and Alzheimer’s disease in the process.
Sep 6, 2022
-
Diagnostics World News | The FDA’s Center for Devices and Radiological Health is seeking to advance innovation in microfluidics-based medical devices with the development of a regulatory science tool for leakage testing. A growing number of diagnostic and therapeutic medical devices use microfluidics technology and leakage testing has emerged as a nontrivial issue that can contribute to device failure.
Sep 1, 2022
-
Diagnostics World News | Impaired heart metabolism, signaled by low adenosine triphosphate levels detected by an MRI test, may be able to predict future sudden cardiac death. If so, the measurement would help answer the million-dollar question of who needs an implantable cardioverter defibrillator to monitor and treat life-threatening electrical problems with the heart.
Sep 1, 2022
-
Diagnostics World News | The relative merits and drawbacks of using antigen tests rather than molecular assays during outbreaks of emerging infectious diseases was the topic of a lively debate held at last week’s Next Generation Dx Summit in Washington, D.C. The team arguing against antigen testing ultimately won the debate by swaying a healthy percentage of the audience to their side.
Aug 31, 2022
-
Diagnostics World News | An ultramodern laboratory for prostate cancer diagnoses opens in Sweden; a flow cytometry-based companion diagnostics platform matches patients with life-changing treatments for cancer and other diseases; a new RNA-targeted oncology pipeline boasts therapeutic and diagnostic capabilities; and more.
Aug 31, 2022
-
Diagnostics World News | The pros and cons of the Verifying Accurate Leading-edge IVCT Development Act, was the topic of a lively panel discussion during last week’s Next Generation Dx Summit in Washington, D.C. Those supporting the legislation, point to several promising provisions added over the past few months as well as the importance of leveling the playing field so all test developers are held to the same evidentiary standard.
Aug 30, 2022
-
Diagnostics World News | Funding for COVID-19 Omicron subvariant surveillance, ultrasensitive genetic optical detection, rapid multi-pathogenic testing, and more.
Aug 30, 2022
-
Diagnostics World News | A long list of clinical services, including point-of-care testing, could be implemented in the community pharmacies which, especially during the pandemic, have become public health destinations. Pharmacists predict that 2022 will be a “banner year” for POC testing in community pharmacies and emerge as test-and-treat locations for infectious conditions beyond COVID.
Aug 26, 2022
-
Diagnostics World News | Oregon Health & Science University researchers created a new imaging technique to predict at-risk pregnancies with funding from the National Institutes of Health’s Human Placenta Project.
Aug 25, 2022
-
Diagnostics World News | The clinical utility of genetic testing has been newly redefined to reflect the realities of modern cancer care. The education, advocacy, and evidence-developing organization, Personalized Medicine Coalition, championed efforts to pen the update through a roundtable event sponsored by Genentech.
Aug 24, 2022